# Immunome Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:035a438c-bf98-42f6-acb8-8f2faa49567d | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/immunome-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 24 | | Claims under review | 1 | | Evidence records | 8 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-09T04:45:54.230704+00:00 | | Last reviewed | 2026-10-09T04:45:54.230704+00:00 | ## Identity - Legal name: Immunome Inc. - Display name: Immunome Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-09T07:12:10.892232+00:00 | | Completeness | 0.409 | | Record Quality | 0.829 | | Directors | 8 | | Committees | 1 | | Governance events | 10 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Carol Schafer: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. claim_id=alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:6 - Clay Siegall, Ph.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-01-01. claim_id=alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:7 - James Boylan: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-01-01. claim_id=alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:9 - Jean-Jacques Bienaimé: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-01-01. claim_id=alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:10 - Philip Wagenheim: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2017-01-01. claim_id=alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:11 - Sandra Swain: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. claim_id=alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:12 - Clay Siegall: President, Chief Executive Officer and Chairman of the Board. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: Chief Executive Officer and Chairman of the Board (member). claim_id=alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:5 - Isaac Barchas: Lead Independent Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:8 ## Committees - Chief Executive Officer and Chairman of the Board (executive). Chair: NOT_PUBLISHED. Members: Clay Siegall (member, unknown). committee_id=alpha:committee:immunome-inc:chief-executive-officer-and-chairman-of-the-board ## Executive leadership - Clay Siegall, Ph.D.: President, Chief Executive Officer and Chairman of the Board [CEO]. Status: current. claim_id=alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:15 - Jack Higgins, Ph.D.: Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:17 - Philip Tsai, Ph.D.: Chief Technical Officer. Status: current. claim_id=alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:21 - Robert Lechleider, M.D.: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:23 - Bob Lechleider, M.D.: Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:13 - Clay Siegall: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:14 - Jack Higgins: Chief Scientific Officer. Status: unknown. claim_id=alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:16 - Kinney Horn: Chief Business Officer. Status: unknown. claim_id=alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:18 - Max Rosett: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:19 - Philip Tsai: Chief Technical Officer. Status: unknown. claim_id=alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:20 - Robert Lechleider: Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:22 - Sandra Stoneman: Chief Legal Officer and General Counsel [GC]. Status: unknown. claim_id=alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:24 ## Governance events - CEO_CHANGED: Clay Siegall, Ph.D. executive of Immunome Inc., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-09T04:45:54.230704+00:00. event_id=alpha:event:transition:1d0gjq81cxbor4 - EXECUTIVE_APPOINTED: Jack Higgins, Ph.D. executive of Immunome Inc., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-09T04:45:54.230704+00:00. event_id=alpha:event:transition:1s54pdk1aynjw0 - EXECUTIVE_APPOINTED: Philip Tsai, Ph.D. executive of Immunome Inc., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-09T04:45:54.230704+00:00. event_id=alpha:event:transition:8t3qrw1h7v8hg - EXECUTIVE_APPOINTED: Robert Lechleider, M.D. executive of Immunome Inc., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-09T04:45:54.230704+00:00. event_id=alpha:event:transition:8a9jrdv3j6wn - DIRECTOR_APPOINTED: Carol Schafer seat on Immunome Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-09T04:45:54.230704+00:00. event_id=alpha:event:transition:88o815ctqzi1 - DIRECTOR_APPOINTED: Sandra Swain seat on Immunome Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-09T04:45:54.230704+00:00. event_id=alpha:event:transition:14mscks187fd1w - DIRECTOR_APPOINTED: Clay Siegall, Ph.D. seat on Immunome Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-09T04:45:54.230704+00:00. event_id=alpha:event:transition:1h0195j1r9o4bz - DIRECTOR_APPOINTED: James Boylan seat on Immunome Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-09T04:45:54.230704+00:00. event_id=alpha:event:transition:1mgnb9f163qdv9 - DIRECTOR_APPOINTED: Jean-Jacques Bienaimé seat on Immunome Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-09T04:45:54.230704+00:00. event_id=alpha:event:transition:19iwz8tuxn1a9 - DIRECTOR_APPOINTED: Philip Wagenheim seat on Immunome Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-09T04:45:54.230704+00:00. event_id=alpha:event:transition:1x5djqvza9oev ## Scoped resources - `alpha://company/immunome-inc` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record - `alpha://company/immunome-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record§ion=identity - `alpha://company/immunome-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record§ion=corporate-structure - `alpha://company/immunome-inc/board` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record§ion=board - `alpha://company/immunome-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record§ion=committees - `alpha://company/immunome-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record§ion=leadership - `alpha://company/immunome-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record§ion=ownership - `alpha://company/immunome-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record§ion=financials - `alpha://company/immunome-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record§ion=capital-structure - `alpha://company/immunome-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record§ion=compensation - `alpha://company/immunome-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record§ion=governance - `alpha://company/immunome-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record§ion=shareholder-governance - `alpha://company/immunome-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record§ion=audit - `alpha://company/immunome-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record§ion=legal - `alpha://company/immunome-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record§ion=risk - `alpha://company/immunome-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record§ion=cyber - `alpha://company/immunome-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record§ion=ai-governance - `alpha://company/immunome-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record§ion=agents - `alpha://company/immunome-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record§ion=ecosystem - `alpha://company/immunome-inc/events` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record§ion=events - `alpha://company/immunome-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record§ion=relationships - `alpha://company/immunome-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record§ion=assessments - `alpha://company/immunome-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/immunome-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Clay Siegall: President, Chief Executive Officer and Chairman of the Board. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b4796807dbc1a611c9b509e455f6f3cca1047b303b37c295c3860bb4a0b92621. - Carol Schafer: Director. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:6. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5fdaec6ba842491ef43140639c4a14b5b29e7f9092453616ec5ddab464f6c411. - Clay Siegall, Ph.D.: Director. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:7. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5fdaec6ba842491ef43140639c4a14b5b29e7f9092453616ec5ddab464f6c411. - Isaac Barchas: Lead Independent Director. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b4796807dbc1a611c9b509e455f6f3cca1047b303b37c295c3860bb4a0b92621. - James Boylan: Director. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:9. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5fdaec6ba842491ef43140639c4a14b5b29e7f9092453616ec5ddab464f6c411. - Jean-Jacques Bienaimé: Director. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:10. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5fdaec6ba842491ef43140639c4a14b5b29e7f9092453616ec5ddab464f6c411. - Philip Wagenheim: Director. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:11. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5fdaec6ba842491ef43140639c4a14b5b29e7f9092453616ec5ddab464f6c411. - Sandra Swain: Director. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:12. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5fdaec6ba842491ef43140639c4a14b5b29e7f9092453616ec5ddab464f6c411. - Bob Lechleider, M.D.: Chief Medical Officer. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1cbc7ce37966efd0ce1102ec5a1e71871a17c0b91a94591b9c57ecc47396ba4e. - Clay Siegall: President and Chief Executive Officer. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b4796807dbc1a611c9b509e455f6f3cca1047b303b37c295c3860bb4a0b92621. - Clay Siegall, Ph.D.: President, Chief Executive Officer and Chairman of the Board. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:15. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:45741fc2eeb5c8badf2239b1a03123f3df37cac0eda19079d524a1e4c82f6b2a. - Jack Higgins: Chief Scientific Officer. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b4796807dbc1a611c9b509e455f6f3cca1047b303b37c295c3860bb4a0b92621. - Jack Higgins, Ph.D.: Chief Scientific Officer. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:17. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0f8da1feece9be1407c099c34f42201917cdad5ee72392bd3296d19e17f0ce57. - Kinney Horn: Chief Business Officer. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b4796807dbc1a611c9b509e455f6f3cca1047b303b37c295c3860bb4a0b92621. - Max Rosett: Chief Financial Officer. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b4796807dbc1a611c9b509e455f6f3cca1047b303b37c295c3860bb4a0b92621. - Philip Tsai: Chief Technical Officer. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b4796807dbc1a611c9b509e455f6f3cca1047b303b37c295c3860bb4a0b92621. - Philip Tsai, Ph.D.: Chief Technical Officer. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:21. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ee0b88a4da17ecc06c503e80c55d8131564eaed58d4ce19f293d6eb7fc2fed94. - Robert Lechleider: Chief Medical Officer. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b4796807dbc1a611c9b509e455f6f3cca1047b303b37c295c3860bb4a0b92621. - Robert Lechleider, M.D.: Chief Medical Officer. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:23. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e04d0738c5087f0813691bcfaf814ef864ae33ecd01d256ab39e76bb6001eea1. - Sandra Stoneman: Chief Legal Officer and General Counsel. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:leadership_role:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b4796807dbc1a611c9b509e455f6f3cca1047b303b37c295c3860bb4a0b92621. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Immunome Inc.. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b8b3dbe6b4440741e443bdfd6001be2acc61cba5e01e282b4ff67e1976f1d0ed. ## Entity Status - Public listing published. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b8b3dbe6b4440741e443bdfd6001be2acc61cba5e01e282b4ff67e1976f1d0ed. ## Published Fact - US. Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b8b3dbe6b4440741e443bdfd6001be2acc61cba5e01e282b4ff67e1976f1d0ed. ## Security Listing - IMNM (NASDAQ). Claim: alpha:claim:company:035a438c-bf98-42f6-acb8-8f2faa49567d:security_listing:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b8b3dbe6b4440741e443bdfd6001be2acc61cba5e01e282b4ff67e1976f1d0ed. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:b8b3dbe6b4440741e443bdfd6001be2acc61cba5e01e282b4ff67e1976f1d0ed: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/immunome-inc). - alpha:projection-evidence:document:b4796807dbc1a611c9b509e455f6f3cca1047b303b37c295c3860bb4a0b92621: [SEC DEF 14A 0001140361-26-016685](https://www.sec.gov/Archives/edgar/data/1472012/000114036126016685/ny20062786x1_def14a.htm). - alpha:projection-evidence:document:5fdaec6ba842491ef43140639c4a14b5b29e7f9092453616ec5ddab464f6c411: [DEF 14A ny20062786x1_def14a.htm](https://www.sec.gov/Archives/edgar/data/1472012/000114036126016685/ny20062786x1_def14a.htm). - alpha:projection-evidence:document:1cbc7ce37966efd0ce1102ec5a1e71871a17c0b91a94591b9c57ecc47396ba4e: IMNM executive roster source. - alpha:projection-evidence:document:45741fc2eeb5c8badf2239b1a03123f3df37cac0eda19079d524a1e4c82f6b2a: [IMNM DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1472012/000114036126016685/ny20062786x1_def14a.htm). - alpha:projection-evidence:document:0f8da1feece9be1407c099c34f42201917cdad5ee72392bd3296d19e17f0ce57: [IMNM DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1472012/000114036126016685/ny20062786x1_def14a.htm). - alpha:projection-evidence:document:ee0b88a4da17ecc06c503e80c55d8131564eaed58d4ce19f293d6eb7fc2fed94: [IMNM DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1472012/000114036126016685/ny20062786x1_def14a.htm). - alpha:projection-evidence:document:e04d0738c5087f0813691bcfaf814ef864ae33ecd01d256ab39e76bb6001eea1: [IMNM DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1472012/000114036126016685/ny20062786x1_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/immunome-inc) - [Public Markdown](https://registry.alpha.ac/companies/immunome-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/immunome-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/immunome-inc?format=jsonld) - MCP resource: `alpha://companies/immunome-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-09T07:12:10.885147+00:00; recorded 2026-10-09T07:12:10.885147+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.